Saving Lives and Reducing Health Care Waste by Improving Diagnosis in Medicine Act
- Sponsor
- Rep. Beyer, Donald S. [D-VA-8]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jul 15, 2026
Bottom line
The bill creates a multi-faceted federal initiative to address diagnostic errors in healthcare through research, reporting, data standardization, and interagency coordination, with significant authorized appropriations.
What it actually does
This bill establishes new federal programs and expands existing ones to improve diagnostic accuracy and safety in healthcare. It mandates a comprehensive research and quality improvement program, creates a patient safety reporting system for diagnostic errors, integrates diagnostic safety into federal training grants and quality measure development, promotes standardized data for diagnosis, and establishes an interagency council to coordinate federal efforts. The bill aims to reduce preventable harm and healthcare waste stemming from diagnostic errors and delays.
Proponents argue
Proponents argue that diagnostic error is a leading cause of preventable harm and waste in the U.S. health system, costing lives and billions of dollars annually. They contend that this bill provides a crucial, coordinated federal response to modernize diagnostic safety infrastructure, leveraging research, data science, patient engagement, and systems learning to improve patient outcomes and reduce healthcare costs.
Opponents contend
Opponents might raise concerns about the expansion of federal programs and associated spending, especially during times of fiscal constraint. They could argue that some of these initiatives might duplicate existing efforts or create unnecessary bureaucratic layers. Concerns might also be raised about the potential for over-regulation in healthcare or the privacy implications of new patient reporting systems, despite the bill's safeguards.
The bill is concise and clearly structured, making it accessible for an informed reader to understand its core provisions within a reasonable timeframe, likely less than the typical time allotted for legislative review.
Section 3, amending Part B of title IX of the Public Health Service Act
Research and Quality Improvement Program
This section establishes a new comprehensive program within the Agency for Healthcare Research and Quality (AHRQ) focused on patient-centered research and quality improvement for diagnostic errors. It aims to understand why errors occur, develop prevention strategies, and disseminate best practices. The program will include a continuum of research activities, establish 'Research centers of diagnostic excellence,' provide financial assistance for these centers, and create a multi-stakeholder advisory committee to guide its implementation.
Supporters argue
Supporters contend that this program is essential for generating the evidence base needed to tackle diagnostic errors, which are currently a major source of patient harm. The focus on patient-centered research and stakeholder collaboration ensures that solutions are relevant and implementable in real-world clinical settings.
Critics contend
Some might argue that existing research bodies could incorporate this focus without creating a new, dedicated program, potentially leading to redundancy or inefficient use of resources. Concerns could also be raised about the scope and oversight of the new research centers.
Tradeoffs
The tension lies between the need for dedicated funding and focus on diagnostic safety versus integrating this work into existing, broader patient safety initiatives. The bill opts for a dedicated program to ensure sufficient attention and resources.
Section 4
Patient Safety Reporting and Learning Infrastructure
This section directs the Director of AHRQ to develop a strategic plan within one year to create mechanisms for patients, families, and caregivers to voluntarily report diagnostic errors and other patient safety events. The reports are strictly for public health and learning, explicitly not admissible in legal proceedings, and will safeguard patient privacy. The plan must leverage modern data science and AI, and align with existing federal patient experience and quality programs.
Section 5
Fellowships and Training Grants for Diagnostic Safety and Quality
This section expands existing federal fellowship and training grant programs to explicitly include diagnostic safety and quality research. Specifically, it amends the Public Health Service Act to ensure that Ruth Kirschstein Awards (NIH's primary mechanism for training future biomedical and behavioral researchers) and AHRQ's training programs recognize diagnostic safety and quality as a legitimate and fundable area of study.
Section 6
Quality Measure Development for Diagnostic Safety and Quality
This section amends the Public Health Service Act to include 'diagnostic safety and quality' as a specific priority area for the development of healthcare quality measures. This means that federal efforts to develop and endorse quality measures will now explicitly consider and prioritize measures related to the accuracy, timeliness, and safety of diagnosis.
Section 7
Standardized Data for Diagnosis Research and Improvement
This section directs the Secretary of Health and Human Services (HHS) to coordinate efforts to promote standardized, interoperable data elements to support diagnostic safety and quality research. It mandates convening an expert panel to recommend specific data elements for the United States Core Data for Interoperability (USCDI) related to patient symptoms, chief complaints, and diagnosis status. The goal is to enhance data capabilities for research and improvement, including the development of symptom-based clinical registries.
Section 8
Interagency Council on Improving Diagnosis in Health Care
This section establishes an Interagency Council within the Office of the Secretary of HHS, tasked with coordinating federal efforts to improve diagnosis in healthcare. The Council, chaired by the AHRQ Director, will include representatives from numerous federal agencies (e.g., CDC, CMS, VA, DoD, NIH institutes, FDA, ONC, HHS CDO, HHS CAIO). Its objectives include enhancing research, eliminating systemic barriers, identifying knowledge gaps, and developing a strategic federal plan with policy recommendations to improve diagnostic safety and quality.
Reports collected under the patient safety reporting system shall not be admissible in civil or criminal proceedings and shall be used solely for public health, improvement, and learning purposes.
Section 4(b)(1)
Why it matters:This is standard legislative practice for specifying legal protections and limitations on data use within a program's operational details. It is not necessarily evasive but could be overlooked by a casual reader.
Case for: Supporters argue this protection is vital to encourage voluntary reporting. Without it, patients and caregivers might fear legal repercussions, undermining the system's ability to collect comprehensive data on diagnostic errors.
Case against: Critics might argue that such protections could limit accountability in cases of severe negligence, though the bill clarifies it does not affect legal rights or remedies available to patients.
Estimated impact: This provision is fundamental to the success of the patient safety reporting system, directly influencing participation rates and the quality of reported data.
The expert panel's recommendations for standardized data elements will specifically consider the fidelity, interoperability, auditability, and socio-technical aspects of electronic vocabularies and ontologies related to presenting symptoms as stated by patients, chief complaints of patients, and the status of diagnosis (such as tentative, working, or confirmed).
Section 7(b)(1)
Why it matters:This level of detail is appropriate for a technical directive to an expert panel. It is not evasive but requires domain-specific knowledge to fully appreciate its significance.
Case for: Proponents argue that these granular details are critical for ensuring that the standardized data elements are truly useful for diagnostic safety research. Capturing patient-stated symptoms and the evolving status of a diagnosis is essential for understanding the diagnostic process.
Case against: Some might argue that such specific technical mandates could become outdated quickly in a rapidly evolving field, or that they might be overly prescriptive, limiting the expert panel's flexibility.
Estimated impact: This provision will significantly influence the quality and utility of future diagnostic data, impacting the effectiveness of research and AI tools in this domain.